SCHEMBL31758136

SCHEMBL31758136

CCOC(=O)CC(=O)Cc1ccccc1OCc1ccccc1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GAA P10253 2/20 0.50
MRGPRX4 Q96LA9 1/20 0.47
HTR1A P08908 2/20 0.47
ADRA1D P25100 1/20 0.47
ADRA1A P35348 1/20 0.47
ADRA1B P35368 1/20 0.47
BRD4 O60885 1/20 0.47
DRD2 P14416 1/20 0.47
PTGER1 P34995 2/20 0.46
PTGER4 P35408 2/20 0.46
PTGER3 P43115 2/20 0.46
PTGER2 P43116 2/20 0.46
L3MBTL1 Q9Y468 3/20 0.46
KDM4E B2RXH2 2/20 0.45
LMNA P02545 2/20 0.45
CFD P00746 1/20 0.45
PLG P00747 1/20 0.45
PLAU P00749 1/20 0.45
F11 P03951 1/20 0.45
KLKB1 P03952 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5661211 0.89 TBXAS1 (0.53) GAAMRGPRX4HTR1ABRD4DRD2
SCHEMBL7145344 0.83 HTR1A (0.54) GAAMRGPRX4HTR1ABRD4DRD2
SCHEMBL29014549 0.82 TSHR (0.57) GAAMAPTALDH1A1MEN1KMT2A
SCHEMBL31757763 0.80 L3MBTL1 (0.56) GAAHTR1ABRD4DRD2PTGER1
SCHEMBL2988197 0.80 L3MBTL1 (0.56) GAAHTR1ABRD4DRD2PTGER1
SCHEMBL319873 0.80 PPID (0.54) GAAL3MBTL1TDP1MAPK1ALDH1A1
SCHEMBL8324677 0.79 L3MBTL1 (0.64) GAAHTR1ABRD4DRD2PTGER1
SCHEMBL377080 0.78 ABCB1 (0.61) GAABRD4PTGER1L3MBTL1LMNA
SCHEMBL7890168 0.78 TBXAS1 (0.59) GAAL3MBTL1KDM4EMAPTTDP1
SCHEMBL28280410 0.78 PPID (0.53) GAAL3MBTL1TDP1MAPK1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260008758-A1 LINEAR DIPEPTIDYL PEPTIDASE 1 INHIBITORS AND USES THEREOF INSMED INCORPORATED 2026-01-08 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260008758-A1 LINEAR DIPEPTIDYL PEPTIDASE 1 INHIBITORS AND USES THEREOF DPP3, DPP7, DPP9 GAA 373/4885MRGPRX4 1259/4885HTR1A 864/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.